SG Americas Securities’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,608
Closed -$101K 3745
2025
Q4
$101K Buy
+13,608
New +$93.2K ﹤0.01% 3238
2025
Q2
Sell
-30,140
Closed -$219K 3641
2025
Q1
$219K Sell
30,140
-5,439
-15% -$42.7K ﹤0.01% 2471
2024
Q4
$285K Buy
35,579
+23,442
+193% +$203K ﹤0.01% 1840
2024
Q3
$89K Buy
+12,137
New +$86.7K ﹤0.01% 3112
2021
Q4
Sell
-20,212
Closed -$112K 3839
2021
Q3
$112K Buy
+20,212
New +$132K ﹤0.01% 3612
2020
Q3
Sell
-20,435
Closed -$196K 3493
2020
Q2
$196K Buy
+20,435
New +$159K ﹤0.01% 2876

Other funds holding VMD

SG Americas Securities's VMD Position: Q1 2026 in Review

SG Americas Securities sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 13,608 shares — an estimated $101K sold.

SG Americas Securities first reported a position in VMD in Q2 2020 and held it in 6 quarters. The position peaked at $285K in Q4 2024. 150 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • SG Americas Securities reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 13,608 Viemed Healthcare shares in Q1 2026, an estimated $101K.
  • SG Americas Securities first reported a position in Viemed Healthcare in Q2 2020 and held it in 6 quarters.
  • SG Americas Securities's Viemed Healthcare position peaked at $285K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.